BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26025125)

  • 1. Fine mapping of the myosin light chain kinase (MYLK) gene replicates the association with asthma in populations of Spanish descent.
    Acosta-Herrera M; Pino-Yanes M; Ma SF; Barreto-Luis A; Corrales A; Cumplido J; Pérez-Rodríguez E; Campo P; Eng C; García-Robaina JC; Quintela I; Villar J; Blanca M; Carracedo Á; Carrillo T; Garcia JG; Torgerson DG; Burchard EG; Flores C
    J Allergy Clin Immunol; 2015 Oct; 136(4):1116-8.e9. PubMed ID: 26025125
    [No Abstract]   [Full Text] [Related]  

  • 2. Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma.
    Gao L; Grant AV; Rafaels N; Stockton-Porter M; Watkins T; Gao P; Chi P; Muñoz M; Watson H; Dunston G; Togias A; Hansel N; Sevransky J; Maloney JP; Moss M; Shanholtz C; Brower R; Garcia JG; Grigoryev DN; Cheadle C; Beaty TH; Mathias RA; Barnes KC
    J Allergy Clin Immunol; 2007 May; 119(5):1111-8. PubMed ID: 17472811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYLK polymorphism associated with blood eosinophil level among asthmatic patients in a Korean population.
    Lee SO; Cheong HS; Park BL; Bae JS; Sim WC; Chun JY; Isbat M; Uh ST; Kim YH; Jang AS; Park CS; Shin HD
    Mol Cells; 2009 Feb; 27(2):175-81. PubMed ID: 19277499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intronic MYLK variant associated with inflammatory lung disease regulates promoter activity of the smooth muscle myosin light chain kinase isoform.
    Han YJ; Ma SF; Wade MS; Flores C; Garcia JG
    J Mol Med (Berl); 2012 Mar; 90(3):299-308. PubMed ID: 22015949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A MYLK variant regulates asthmatic inflammation via alterations in mRNA secondary structure.
    Wang T; Zhou T; Saadat L; Garcia JG
    Eur J Hum Genet; 2015 Jun; 23(6):874-6. PubMed ID: 25271083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common cortactin gene variation confers differential susceptibility to severe asthma.
    Ma SF; Flores C; Wade MS; Dudek SM; Nicolae DL; Ober C; Garcia JG
    Genet Epidemiol; 2008 Dec; 32(8):757-66. PubMed ID: 18521921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A variant of the myosin light chain kinase gene is associated with severe asthma in African Americans.
    Flores C; Ma SF; Maresso K; Ober C; Garcia JG
    Genet Epidemiol; 2007 May; 31(4):296-305. PubMed ID: 17266121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in the myosin light chain kinase gene is associated with development of acute lung injury after major trauma.
    Christie JD; Ma SF; Aplenc R; Li M; Lanken PN; Shah CV; Fuchs B; Albelda SM; Flores C; Garcia JG
    Crit Care Med; 2008 Oct; 36(10):2794-800. PubMed ID: 18828194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYLK pathogenic variants aortic disease presentation, pregnancy risk, and characterization of pathogenic missense variants.
    Wallace SE; Regalado ES; Gong L; Janda AL; Guo DC; Russo CF; Kulmacz RJ; Hanna N; Jondeau G; Boileau C; Arnaud P; Lee K; Leal SM; Hannuksela M; Carlberg B; Johnston T; Antolik C; Hostetler EM; Colombo R; Milewicz DM
    Genet Med; 2019 Jan; 21(1):144-151. PubMed ID: 29925964
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Cho HW; Jin HS; Eom YB
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33800915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel polymorphisms in the myosin light chain kinase gene confer risk for acute lung injury.
    Gao L; Grant A; Halder I; Brower R; Sevransky J; Maloney JP; Moss M; Shanholtz C; Yates CR; Meduri GU; Shriver MD; Ingersoll R; Scott AF; Beaty TH; Moitra J; Ma SF; Ye SQ; Barnes KC; Garcia JG
    Am J Respir Cell Mol Biol; 2006 Apr; 34(4):487-95. PubMed ID: 16399953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel MYLK nonsense mutations causing thoracic aortic aneurysms/dissections in patients without apparent family history.
    Luyckx I; Proost D; Hendriks JMH; Saenen J; Van Craenenbroeck EM; Vermeulen T; Peeters N; Wuyts W; Rodrigus I; Verstraeten A; Van Laer L; Loeys BL
    Clin Genet; 2017 Oct; 92(4):444-446. PubMed ID: 28401540
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure-Function Analysis of the Non-Muscle Myosin Light Chain Kinase (nmMLCK) Isoform by NMR Spectroscopy and Molecular Modeling: Influence of MYLK Variants.
    Shen K; Ramirez B; Mapes B; Shen GR; Gokhale V; Brown ME; Santarsiero B; Ishii Y; Dudek SM; Wang T; Garcia JG
    PLoS One; 2015; 10(6):e0130515. PubMed ID: 26111161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data.
    Tan X; Chen M
    Tumour Biol; 2014 Dec; 35(12):12189-200. PubMed ID: 25179839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic regulation of the non-muscle myosin light chain kinase isoform by lung inflammatory factors and mechanical stress.
    Sun X; Sun BL; Sammani S; Bermudez T; Dudek SM; Camp SM; Garcia JGN
    Clin Sci (Lond); 2021 Apr; 135(7):963-977. PubMed ID: 33792658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myosin light chain kinase gene is not duplicated in mouse: partial structure and chromosomal localization of Mylk.
    Giorgi D; Ferraz C; Mattéi MG; Demaille J; Rouquier S
    Genomics; 2001 Jul; 75(1-3):49-56. PubMed ID: 11472067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of long noncoding RNA MYLK-AS1 suppresses nephroblastoma via down-regulation of CCNE1 through transcription factor TCF7L2.
    Zhu S; Zhang J; Gao X; Tang X; Cui Y; Li D; Jia W
    J Cell Physiol; 2021 Aug; 236(8):5757-5770. PubMed ID: 33438217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway.
    Chen S; Lv L; Zhan Z; Wang X; You Z; Luo X; You H
    J Cell Physiol; 2020 Nov; 235(11):7757-7768. PubMed ID: 31742692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
    Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circRNA-MYLK plays oncogenic roles in the Hep-2 cell line by sponging microRNA-145-5p.
    Chen Y; Wang Y; Li Y; Li X; Yuan T; Yang S; Sun X
    Gen Physiol Biophys; 2020 May; 39(3):229-237. PubMed ID: 32525816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.